Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

One Acetaminophen Headache Remains Untreated: Acronyms On Pharmacy Containers

Executive Summary

FDA hopes to curtail acetaminophen overdosing by requiring manufacturers to restrict the amount of the drug in combination Rx products. But another potential cause of overdosing remains intact: the use of acronyms on pharmacy labels.
Advertisement

Related Content

Pressure Builds For Revamped Acetaminophen Warnings In Rx Dispensing Materials
Pressure Builds For Revamped Acetaminophen Warnings In Rx Dispensing Materials
FDA's Chicken Or Egg Question For Pharmacy Leaflets: Should Benefit Or Risk Come First?
FDA Restrictions On Rx Acetaminophen Show How Practical Concerns Influence Safety Actions
FDA Restrictions On Rx Acetaminophen Show How Practical Concerns Influence Safety Actions
McNeil Exec Calls For Uniform Use Of "Acetaminophen" Name

Topics

Advertisement
UsernamePublicRestriction

Register

PS053062

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel